×




Genzyme Center (C) Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Genzyme Center (C) case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Genzyme Center (C) case study is a Harvard Business School (HBR) case study written by Michael W. Toffel, Aldo Sesia. The Genzyme Center (C) (referred as “Leed Building” from here on) case study provides evaluation & decision scenario in field of Technology & Operations. It also touches upon business topics such as - Value proposition, Innovation, Operations management, Project management, Social responsibility, Sustainability.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Genzyme Center (C) Case Study


Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green building rating scheme, the CEO charged the building team with exploring opportunities that would enable the building to earn the highest rating, LEED Platinum. Five additional green building features are described, and students are asked to analyze and recommend which, if any, of these features to pursue based on their cost, likelihood of earning LEED credits, and their influence on the building's environmental performance.


Case Authors : Michael W. Toffel, Aldo Sesia

Topic : Technology & Operations

Related Areas : Innovation, Operations management, Project management, Social responsibility, Sustainability




Calculating Net Present Value (NPV) at 6% for Genzyme Center (C) Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10003391) -10003391 - -
Year 1 3468828 -6534563 3468828 0.9434 3272479
Year 2 3957939 -2576624 7426767 0.89 3522552
Year 3 3955604 1378980 11382371 0.8396 3321201
Year 4 3224761 4603741 14607132 0.7921 2554313
TOTAL 14607132 12670545




The Net Present Value at 6% discount rate is 2667154

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Net Present Value
3. Internal Rate of Return
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Leed Building shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Leed Building have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Genzyme Center (C)

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Technology & Operations Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Leed Building often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Leed Building needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10003391) -10003391 - -
Year 1 3468828 -6534563 3468828 0.8696 3016372
Year 2 3957939 -2576624 7426767 0.7561 2992771
Year 3 3955604 1378980 11382371 0.6575 2600874
Year 4 3224761 4603741 14607132 0.5718 1843768
TOTAL 10453784


The Net NPV after 4 years is 450393

(10453784 - 10003391 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10003391) -10003391 - -
Year 1 3468828 -6534563 3468828 0.8333 2890690
Year 2 3957939 -2576624 7426767 0.6944 2748569
Year 3 3955604 1378980 11382371 0.5787 2289123
Year 4 3224761 4603741 14607132 0.4823 1555151
TOTAL 9483532


The Net NPV after 4 years is -519859

At 20% discount rate the NPV is negative (9483532 - 10003391 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Leed Building to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Leed Building has a NPV value higher than Zero then finance managers at Leed Building can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Leed Building, then the stock price of the Leed Building should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Leed Building should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What will be a multi year spillover effect of various taxation regulations.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Genzyme Center (C)

References & Further Readings

Michael W. Toffel, Aldo Sesia (2018), "Genzyme Center (C) Harvard Business Review Case Study. Published by HBR Publications.


Queclink Wireless SWOT Analysis / TOWS Matrix

Technology , Communications Equipment


SomnoMed Ltd SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


Curexo SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


PUC SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Marufuji Sheet Piling SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


China Outfitters SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


Dechra Pharma SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs